日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

[Clinical characteristics of 11 patients with chronic lymphocytic leukemia with t (14;19) (q32;q13)]

[11例伴有t(14;19)(q32;q13)的慢性淋巴细胞白血病患者的临床特征]

Cui, C H; Chang, Y N; Zhou, J; Li, C W; Wang, H J; Sun, Q; Jia, Y J; Li, Q H; Wang, T Y; Qiu, L G; Yi, S H

[Advances in clinical diagnosis and treatment of drug-induced liver injury in children]

[儿童药物性肝损伤的临床诊断和治疗进展]

Peng, X R; Chang, Y N; Qin, T; Shang, T T; Xu, H M

[Clinical effect and influencing factors of pegylated interferon alfa-2a and entecavir monotherapy among children with HBeAg-positive chronic hepatitis B based on a real-world study]

[基于真实世界研究的聚乙二醇干扰素α-2a联合恩替卡韦单药治疗HBeAg阳性慢性乙型肝炎患儿的临床疗效及影响因素]

Wang, H M; Zhou, Y Z; Chang, Y N; He, Y; Peng, X R; Hu, P; Ren, H; Xu, H M

[Progress in diagnosis and treatment of viral hepatitis in children]

[儿童病毒性肝炎诊断和治疗进展]

Chang, Y N; Xu, H M

[Analysis of liver pathological characteristics and exploration of noninvasive markers of liver fibrosis in children with chronic hepatitis B]

【慢性乙型肝炎患儿肝脏病理特征分析及肝纤维化无创标志物探索】

Liang, C F; Chang, Y N; Peng, X R; He, Y; Chen, M; Peng, M L; Hu, P; Ren, H; Xu, H M

[Correlation of qAnti-HBc with antiviral efficacy in children with chronic hepatitis B and exploration of its possible immune mechanism].

[qAnti-HBc 与慢性乙型肝炎患儿抗病毒疗效的相关性及其可能的免疫机制探讨]

Zhou Y Z, Chang Y N, He Y, Wang H M, Peng X R, Chen M, Peng M L, Hu P, Ren H, Xu H M

The palindromic series I repeats in the simian cytomegalovirus major immediate-early promoter behave as both strong basal enhancers and cyclic AMP response elements

猿猴巨细胞病毒主要即刻早期启动子中的回文序列 I 重复既是强基础增强子,又是环磷酸腺苷 (cAMP) 反应元件。

Chang, Y N; Crawford, S; Stall, J; Rawlins, D R; Jeang, K T; Hayward, G S

Identification of immediate-early-type cis-response elements in the promoter for the ribonucleotide reductase large subunit from herpes simplex virus type 2

单纯疱疹病毒2型核糖核苷酸还原酶大亚基启动子中即刻早期型顺式反应元件的鉴定

Wymer, J P; Chung, T D; Chang, Y N; Hayward, G S; Aurelian, L